Toledo, Vitiliano C.
HRN: 02-13-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/13/2024
02/20/2024
IV
600mg
Q8
Mva
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes